CG Oncology Inc.
Leonard E Post (Director) sells CGON shares
About this filing
CG Oncology Inc. (CGON) filed Form 4 (insider transaction) with the SEC on Oct 19, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Leonard E Post · Director
Rule 10b5-1 plan · adopted Mar 5, 2026
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | M · exercise or conversion of a derivative | +1,000 | $0.60 | $600.00 | 1,000 | Direct |
| Oct 15, 2026 | S · open-market saleFootnotes F1, F2 | −500 | $61.65 | $30,825.00 | 500 | Direct |
| Oct 15, 2026 | S · open-market saleFootnotes F1, F3 | −500 | $62.48 | $31,240.00 | 0 | Direct |
| Oct 15, 2026 | M · exercise or conversion of a derivativeDirector Stock Option (right to buy)Footnotes F4 | −1,000 | $0.00 | $0.00 | 102,077 | Direct |
Footnotes
- F1 The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2026.
- F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.16 to $62.06 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.27 to $62.60 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F4 Fully vested
More CGON filings
- 4
Filed Nov 17, 2026
- 8-K
Filed Nov 16, 2026
- 10-Q
Filed Nov 6, 2026
- 8-K
Filed Nov 6, 2026
- 4
Filed Oct 19, 2026
- 3
Filed Oct 19, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.